Literature DB >> 19410429

CSF 5-HIAA, attempted suicide and suicide risk in schizophrenia spectrum psychosis.

Andreas Carlborg1, Jussi Jokinen, Anna-Lena Nordström, Erik G Jönsson, Peter Nordström.   

Abstract

INTRODUCTION: There is evidence for a relationship between low levels of 5-hydroxyindoleacetic acid (5-HIAA) in cerebrospinal fluid (CSF) and suicidal behavior in mood disorder. A relationship between CSF homovanillic acid (HVA) and suicidal behavior has not been completely established. Studies done in patients with schizophrenia spectrum psychosis suffer from small numbers, short periods of follow-up and the results are contradictory. The objective of this study was to investigate the relationship between levels of CSF 5-HIAA, CSF HVA and suicidal behavior in patients with schizophrenia spectrum psychosis.
METHOD: Three hundred eighty five patients with schizophrenia spectrum psychosis admitted to the Karolinska University Hospital between 1973 and 1987 were lumbar punctured in standardized manner. Patients were followed until 2006 for a median of 26 years. Information about prior suicide attempt was retrieved from medical records and causes of death were obtained from the Causes of Death Register at the National Board of Health and Welfare.
RESULTS: At the end of the follow-up 26 patients (6.8%) had died by suicide. Male gender (OR=3.5) and attempted suicide (OR=12.4) were risk factor for suicide when combined. There were no significant correlations between levels of CSF 5-HIAA, CSF HVA, HVA/5-HIAA ratio and attempted, violent or non-violent suicide.
CONCLUSION: Male schizophrenia spectrum psychosis patients with prior suicide attempt are at high risk for suicide. No correlation between CSF monoamine metabolites levels and suicidal behavior was found. Suicidal behavior in schizophrenia spectrum psychosis may not, in contrast to mood disorders, be predicted by levels of CSF 5-HIAA and HVA.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19410429     DOI: 10.1016/j.schres.2009.04.006

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  7 in total

1.  Insomnia and suicidal ideation in nonaffective psychosis.

Authors:  Brian J Miller; Carmen B Parker; Mark H Rapaport; Peter F Buckley; William V McCall
Journal:  Sleep       Date:  2019-02-01       Impact factor: 5.849

Review 2.  Suicide and schizophrenia: a systematic review of rates and risk factors.

Authors:  Kahyee Hor; Mark Taylor
Journal:  J Psychopharmacol       Date:  2010-11       Impact factor: 4.153

3.  Suicidal behavior in schizophrenia may be related to low lipid levels.

Authors:  Babajohn Ainiyet; Janusz K Rybakowski
Journal:  Med Sci Monit       Date:  2014-08-21

Review 4.  Neuromodulation, Emotional Feelings and Affective Disorders.

Authors:  Fushun Wang; Alfredo Pereira
Journal:  Mens Sana Monogr       Date:  2016 Jan-Dec

5.  Consensus on potential biomarkers developed for use in clinical tests for schizophrenia.

Authors:  Ping Lin; Junyu Sun; Xiaoyan Lou; Dan Li; Yun Shi; Zhenhua Li; Peijun Ma; Ping Li; Shuzi Chen; Weifeng Jin; Shuai Liu; Qing Chen; Qiong Gao; Lili Zhu; Jie Xu; Mengyuan Zhu; Mengxia Wang; Kangyi Liang; Ling Zhao; Huabin Xu; Ke Dong; Qingtian Li; Xunjia Cheng; Jinghong Chen; Xiaokui Guo
Journal:  Gen Psychiatr       Date:  2022-02-23

6.  Polymorphisms in genes implicated in dopamine, serotonin and noradrenalin metabolism suggest association with cerebrospinal fluid monoamine metabolite concentrations in psychosis.

Authors:  Dimitrios Andreou; Erik Söderman; Tomas Axelsson; Göran C Sedvall; Lars Terenius; Ingrid Agartz; Erik G Jönsson
Journal:  Behav Brain Funct       Date:  2014-07-29       Impact factor: 3.759

7.  Risk factors for suicide among patients with schizophrenia: a cohort study focused on cerebrospinal fluid levels of homovanillic acid and 5-hydroxyindoleacetic acid.

Authors:  Daniel Neider; Leif H Lindström; Robert Bodén
Journal:  Neuropsychiatr Dis Treat       Date:  2016-07-11       Impact factor: 2.570

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.